Crinetics Pharmaceuticals Statistics

Total Valuation

CRNX has a market cap or net worth of $2.83 billion. The enterprise value is $1.69 billion.

Market Cap	2.83B
Enterprise Value	1.69B

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CRNX has 94.18 million shares outstanding. The number of shares has increased by 30.19% in one year.

Current Share Class	94.18M
Shares Outstanding	94.18M
Shares Change (YoY)	+30.19%
Shares Change (QoQ)	+0.74%
Owned by Insiders (%)	1.49%
Owned by Institutions (%)	108.54%
Float	92.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,035.74
Forward PS	160.70
PB Ratio	2.42
P/TBV Ratio	2.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1,212.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.80, with a Debt / Equity ratio of 0.04.

Current Ratio	17.80
Quick Ratio	17.49
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.94% and return on invested capital (ROIC) is -25.12%.

Return on Equity (ROE)	-36.94%
Return on Assets (ROA)	-23.77%
Return on Invested Capital (ROIC)	-25.12%
Return on Capital Employed (ROCE)	-34.64%
Revenue Per Employee	$3,185
Profits Per Employee	-$846,302
Employee Count	437
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.30% in the last 52 weeks. The beta is 0.33, so CRNX's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-39.30%
50-Day Moving Average	30.46
200-Day Moving Average	38.65
Relative Strength Index (RSI)	52.96
Average Volume (20 Days)	949,234

Short Selling Information

The latest short interest is 13.17 million, so 13.99% of the outstanding shares have been sold short.

Short Interest	13.17M
Short Previous Month	12.24M
Short % of Shares Out	13.99%
Short % of Float	14.20%
Short Ratio (days to cover)	16.39

Income Statement

In the last 12 months, CRNX had revenue of $1.39 million and -$369.83 million in losses. Loss per share was -$4.12.

Revenue	1.39M
Gross Profit	-244.63M
Operating Income	-423.06M
Pretax Income	-258.54M
Net Income	-369.83M
EBITDA	-419.62M
EBIT	-423.06M
Loss Per Share	-$4.12

Full Income Statement

Balance Sheet

The company has $1.20 billion in cash and $49.94 million in debt, giving a net cash position of $1.15 billion or $12.17 per share.

Cash & Cash Equivalents	1.20B
Total Debt	49.94M
Net Cash	1.15B
Net Cash Per Share	$12.17
Equity (Book Value)	1.17B
Book Value Per Share	12.45
Working Capital	1.15B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$299.77 million and capital expenditures -$6.00 million, giving a free cash flow of -$305.77 million.

Operating Cash Flow	-299.77M
Capital Expenditures	-6.00M
Free Cash Flow	-305.77M
FCF Per Share	-$3.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-30,392.17%
Pretax Margin	-26,568.53%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRNX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.19%
Shareholder Yield	-30.19%
Earnings Yield	-13.05%
FCF Yield	-10.79%

Analyst Forecast

The average price target for CRNX is $74.33, which is 147.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$74.33
Price Target Difference	147.03%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	309.47%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CRNX has an Altman Z-Score of 18.53 and a Piotroski F-Score of 2.

Altman Z-Score	18.53
Piotroski F-Score	2